Dr. Anastasios Dimou, MD

Dr. Dimou practices at Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota.

Dr. Dimou's NPI, 1265729834, was assigned on July 5, 2011. Dr. Dimou graduated from University of Athens in 2007. Dr. Dimou's Minnesota license number on file is 65825.

Dr. Dimou's primary practice is Mayo Clinic Breast Diagnostic Clinic, at 200 First Street SW, Rochester, MN 55905. The practice phone is (507) 284-5968.

Dr. Dimou's primary practice is Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota. Dr. Dimou is also affiliated with Mayo Clinic Hospital, Saint Marys Campus. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Dimou to 3 more hospitals, 1 clinical lab and 1 hospice, each named with a free account. Dr. Dimou's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dimou practices, 7 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Dimou's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Dimou's licenses on file in 4 states: Minnesota, Colorado, South Carolina and Pennsylvania.

Dmand AI lists breast cancer, colorectal cancer, lung cancer, multiple myeloma, neutropenia, prostate cancer and purpura and thrombocytopenia among the conditions Dr. Dimou treats.

CMS data shows 44,191 Medicare services from Dr. Dimou across 41 procedure codes in 2024, for 500 Medicare patients. Medicare paid $836,318 for them. Every service was in an office.

CMS counts 500 Medicare patients who saw Dr. Dimou in 2024. The largest group is 65 to 74, with 270 patients. 63% of them have high blood pressure, and 59% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dimou's median patient age at 71, with 51% women.

In 2024, Dr. Dimou wrote 495 Medicare Part D claims for 117 patients. 80% of them were for generic drugs. CMS names the drug for 321 of them, across 13 drugs with 11 or more claims each, at $787,921 in total drug cost. In 2023, CMS named 251 claims across 11 drugs.

Dr. Dimou accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dimou as offering telehealth.

Dmand AI links 88 papers to Dr. Dimou, published from 2010 to 2025. 2014 was the busiest year, with 9. The most frequent topics are Lung Neoplasms, Carcinoma, Non-Small-Cell Lung and Antineoplastic Combined Chemotherapy Protocols. Dr. Dimou has published most often in JOP. Dr. Dimou's most frequent co-authors are Svetomir N. Markovic, MD, Matthew S. Block, MD, PhD and Robert Doebele, MD.

Dmand AI links Dr. Dimou to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Melanoma and Nevi and Melanomas.

CMS Open Payments shows 12 general payments to Dr. Dimou from 8 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 42% of the total. Rigel Pharmaceuticals, Inc. paid the most, $3,273. It also lists 1 research payment totaling $1,012 in 2025.

Dmand AI lists 1 award for Dr. Dimou, most recently Young Investigator Award for Translational Cancer Research in 2018.

Dr. Dimou graduated from University of Athens in 2007. Dr. Dimou is a member of ASCO.

Dr. Dimou is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.